BlogFDA adds survival warning to anemia drug labelsThe U.S. Food and Drug Administration ordered that warnings on the labels note that Amgen Inc's, Aranesp and other anemia drugs have been shown to impair survival in some cancer patients. The drugs shortened survival or caused rapid tumor growth. The FDA affixed a warning to the labels of Aranesp, Procrit as well as Amgen's Epogen after studies showed increased risk of death for some patients. There has been steady negative news about the drugs. http://www.reuters.com/article/email/idUSN0736272020080307 ?? ??
FDA adds survival warning to anemia drug labels The FDA affixed a warning to the labels of Aranesp, Procrit as well as Amgen's Epogen after studies showed increased risk of death for some patients. There has been steady negative news about the drugs.
CDC warns of safety problems at clinics The Nevada health officials are trying to contact about 40, 000 patients who received anesthesia by injection. This is the largest number of patients that have ever been contacted for blood exposure. It may never be known how many people contracted hepatitis due to unsafe practices. It is expected to get numerous positive results The FDA affixed a warning to the labels of Aranesp, Procrit as well as Amgen's Epogen after studies showed increased risk of death for some patients. There has been steady negative news about the drugs. Topics
Civil Lawsuit Cases Recent UpdatesAugust 07, 2008 August 01, 2008 July 24, 2008 July 17, 2008 July 09, 2008 Archives |
